Word Of Mouth At EmisphereBy
The stock of Emisphere Technol Jan. 14 above 23. No, this little drug outfit hasn't come up with a cure for cancer. In fact, it has yet to produce revenues. What gives?
To continue reading this article you must be a Bloomberg Professional Service Subscriber.
If you believe that you may have received this message in error please let us know.